These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antifungals in Clinical Use and the Pipeline. Johnson MD Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281 [TBL] [Abstract][Full Text] [Related]
3. Recent approaches to antifungal therapy for invasive mycoses. Mathew BP; Nath M ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067 [TBL] [Abstract][Full Text] [Related]
4. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances]. Cuenca-Estrella M Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554 [TBL] [Abstract][Full Text] [Related]
9. Management of invasive fungal infections: a role for polyenes. Chandrasekar P J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787 [TBL] [Abstract][Full Text] [Related]
11. The value of amphotericin B in the treatment of invasive fungal infections. Klepser M J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541 [TBL] [Abstract][Full Text] [Related]
12. Antifungal drug resistance mechanisms. Pemán J; Cantón E; Espinel-Ingroff A Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764 [TBL] [Abstract][Full Text] [Related]
13. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic implications for use of antifungal agents. Lewis RE Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480 [TBL] [Abstract][Full Text] [Related]